10.01.11
Nutraceutical: Barley beta-glucan (Barliv barley betafiber)
Indication: Pre-diabetes
Source: Nutr Metab, August 16, 2011;8(1):58.
Research: This 12-week randomized, placebo-controlled, double-blind, clinical trial assessed the impact of barley beta-glucan (Barliv barley betafiber) on glucose levels and insulin sensitivity. Because weight changes can impact both of these variables, researchers took steps to ensure that the 50 healthy participants—each at risk for type 2 diabetes mellitus—kept their weight constant during the trial period. Participants consumed three low-dose (3 grams Barliv barley betafiber/day) or high-dose (6 grams Barliv barley betafiber/day) 11-ounce test beverages each day with their meals.
Results: The findings suggest that 6 grams/day of Barliv barley betafiber over 12 weeks can improve insulin sensitivity among generally healthy people with pre-diabetes, who have no prior diagnosis of diabetes mellitus and no change in body weight.
Indication: Pre-diabetes
Source: Nutr Metab, August 16, 2011;8(1):58.
Research: This 12-week randomized, placebo-controlled, double-blind, clinical trial assessed the impact of barley beta-glucan (Barliv barley betafiber) on glucose levels and insulin sensitivity. Because weight changes can impact both of these variables, researchers took steps to ensure that the 50 healthy participants—each at risk for type 2 diabetes mellitus—kept their weight constant during the trial period. Participants consumed three low-dose (3 grams Barliv barley betafiber/day) or high-dose (6 grams Barliv barley betafiber/day) 11-ounce test beverages each day with their meals.
Results: The findings suggest that 6 grams/day of Barliv barley betafiber over 12 weeks can improve insulin sensitivity among generally healthy people with pre-diabetes, who have no prior diagnosis of diabetes mellitus and no change in body weight.